- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Kingdon Describes Reactions to Increasing Use of CBT for Psychosis
David Kingdon, MD, professor of mental health care delivery, University of Southampton, explained that mental health professionals have been receptive to the use of cognitive behavioral therapy (CBT) in psychosis, but there needs to be greater expansion to increase availability.
David Kingdon, MD, professor of mental health care delivery, University of Southampton, explained that mental health professionals have been receptive to the use of cognitive behavioral therapy (CBT) in psychosis, but there needs to be greater expansion to increase availability.
Transcript
In your experience, have mental health care providers and patients been receptive to the increasing use of CBT in psychosis?
I think when we’ve met people and talked with them and when they’ve understood what’s involved, they have been very receptive, because it is something that patients value very, very much, and carers value, so we did a number of sessions at the National Alliance for the Mentally Ill last year, which went down really well; we had a great time there, lot of sharing of experience and understanding. But in terms of service providers, in the UK particularly it’s become quite widespread, but it’s also happening in the US as well, and I think CBT techniques are used partly in some of the early intervention programs that are developing and elsewhere. But we really do need a much greater expansion of training and also just implementation, because it could be very valuable to a lot of people and it’s not really getting there yet.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
